All Cancer articles – Page 4
-
News
Chemistry graduate student gets seven years for poisoning co-worker
Chinese PhD student spiked colleague’s food and water with carcinogen
-
Research
Self-powered cancer therapy triple whammy
Diagnosis, drug delivery and effectiveness monitoring combination could realise precision cancer therapy
-
News
Chemistry graduate student admits poisoning co-worker
Victim at Queen’s University in Canada videoed carcinogen being pipetted into a loaf of bread while he was in a group meeting
-
Research
Deep tissue penetration allows fluorophore to guide tumour surgery
Bioimaging probe excited by longer wavelengths of light but doesn’t suffer from long-term retention in the immune system
-
Opinion
Passing through checkpoints
A new breed of cancer treatments highlights what’s possible when industry concentrates its efforts
-
Business
Cancer immunotherapy spreads rapidly
New approvals and expanded use for checkpoint inhibitor drugs illustrate the power of Nobel-winning science
-
News
MacArthur ‘genius’ fellowships recognise biophysicist and analytical chemist
Foundation awards ‘no strings’ grants for cellular compartmentalisation and cancer surgery research
-
News
Immune-stimulating cancer treatment takes 2018 medicine Nobel
James Allison and Tasuku Honjo receive science’s highest honour for discovering how cancer stops immune cells from attacking
-
Research
Simple test behind early cancer diagnosis breakthrough
Technique combines rolling circle amplification with time-gated Förster resonance energy transfer to detect cancer microRNA
-
Business
Landmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
News
Food agency wades into Californian coffee cancer labels controversy
US body speaks out against ruling that may force cancer warnings on coffee sold in the state due to acrylamide
-
Business
Europe opens gates to CAR-T
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
-
Research
Artificial intelligence seeks out new anticancer drugs
A combination of machine learning methods yields promising results for drug discovery
-
Business
J&J hit with bill for $4.7 billion in damages over talcum powder cancer link
Pharmaceutical and consumer goods giant loses another talc court case to 22 ovarian cancer patients
-
Business
J&J and the question of shadow research
Former academic researcher who found that talc is not carcinogenic admits that J&J funded his work, but says that fact is immaterial
-
Business
BMS stimulates cancer drug hopes with giant collaboration
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders
-
Business
Bayer forms cancer-drug partnership with Loxo
Alliance could see Loxo net up to $1.55bn in upfront and milestone payments
-
News
Furan in food worries European safety agency
Levels of cooking contaminant that can damage liver flagged up by food body
-
Research
Error-free next-generation DNA sequencing pioneered
Algorithmic fix allows ultra-accurate sequencing of rare cancers and genetic conditions
-
Business
Lilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments